 - Patients should have been treated with 4 cycles of induction chemotherapy utilizing the following regimens: carboplatinpaclitaxel, carboplatingemcitabine, carboplatinpaclitaxel bevacizumab, carboplatingemcitabine bevacizumab, or carboplatinpemetrexed - bevacizumab, see Section 3.2 for acceptable doses and schedules and should have CR, PR, or SD as best response. 